Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...

Additional drug combinations may carry a risk of more side effects though, raising concerns from some doctors. Regeneron ...

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug ...

From today, June 23, GPs can prescribe Mounjaro, a weight loss injection, to certain patients on the NHS. The drug, also ...

Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with ...

Prescriptions for Mounjaro jabs, an effective weight loss pill, are now accessible at general practitioners' surgeries in ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

How do weight loss drugs like Ozempic and Mounjaro work? Administered as weekly jabs, these drugs – often called GLP-1 ...

Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.

Novo Nordisk announced it will stop collaborating with Hims & Hers Health regarding the distribution of Wegovy weight loss ...